---
$id: https://graph.org.ai/products/commodity/51183903
$type: Product
source: UNSPSC
code: "51183903"
title: "Tesaglitazar"
class: "51183900"
classTitle: "Antidiabetic and hyperglycemic peroxisome proliferator-activated receptors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tesaglitazar

**UNSPSC Code**: 51183903
**Class**: [Antidiabetic and hyperglycemic peroxisome proliferator-activated receptors](Antidiabetic and hyperglycemic peroxisome proliferator-activated receptors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 6734037O3L. European Medicines Agency schedules Tesaglitazar in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25217. Tesaglitazar generally arises in the molecular formula C20H24O7S. The term TESAGLITAZAR is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16., no. 1.2002, list 47.) Most nations, for tariff and trade purposes, schedule tesaglitazar under HS 29189900 and SITC 51396. As of Q4 2014, TESAGLITAZAR remains US FDA's Preferred Term for this commodity. Tesaglitazar bears US NLM identifiers UMLS ID C1570259 and NCI Concept Code C75985. SMILES: S(=O)(=O)(OC1CCC(CCOC2CCC(CC(OCC)C(=O)O)CC2)CC1)C.

